Evidence map›Paper›PMID 42266268›Full record

ArticlePaediatrics & child health2026

Streamlining Kawasaki disease care: a quality improvement initiative to safely reduce length of stay.

Audrea Chen, Beth D Gamulka, Hanof Alkhdher, Macarena Palomer, Rae S M Yeung

Abstract read
In one paragraph

Article in Paediatrics & child health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Audrea ChenDivision of Paediatric Rheumatology, Department of Paediatrics, Stollery Children's Hospital, University of Alberta, Edmonton, Alberta, Canada.ORCID https://orcid.org/0000-0001-6526-5729
Beth D GamulkaDivision of Paediatric Medicine, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Hanof AlkhdherDivision of Paediatric Rheumatology, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Macarena PalomerDivision of Paediatric Medicine, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Rae S M YeungDivision of Paediatric Rheumatology, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Kawasaki Disease is the most common cause of paediatric acquired heart disease and one of the most resource-intensive acute paediatric conditions to treat. Hospitalization for Kawasaki Disease is a stressful event for children and caregivers, leading to increased use of emergency resources after resolution of disease. A quality improvement clinical pathway was introduced to alleviate strain on inpatient resources and reduce length of stay by 33% over 12 months. Methods: All patients diagnosed and treated for Kawasaki Disease at this institution were included. The primary outcome measure was length of stay. Patients with complicated Kawasaki Disease (i.e., Admission to intensive care) were excluded from outcome measurement, however process and balancing measures were collected for all patients. Balancing measures included rate of urgent care access post-discharge and patient satisfaction. Results: Forty-nine patients were included in the study, with length of stay data collected for 19. The average length of stay was 46 hours (17% reduction from a pre-intervention baseline of 55 hours). Process measures showed >75% uptake in change ideas following two plan, do, study, act (PDSA) cycles. Patient satisfaction was high with no safety concerns after discharge. Approximately $25,402 was saved over 49 admissions through reductions in length of stay and laboratory investigations. Conclusion: While the primary objective was not met, a sustained 17% reduction in length of stay was achieved without compromising patient safety or satisfaction. This initiative successfully implemented a standardized clinical pathway through strong collaborator engagement and patient-driven change ideas.

Indexed as

Clinical PathwaysMucocutaneous Lymph Node SyndromePatient Care ManagementQuality Improvement

Identifiers

PMID42266268
PMCPMC13245165

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.